In English
NIDA

La heroina: Abuso y addición

Referencias

  1. Community Epidemiology Work Group. Epidemiologic Trends in Drug Abuse, Vol. II, Proceedings of the Community Epidemiology Work Group, December 2003. NIH Pub. No. 04-5365. Bethesda, MD: NIDA, NIH, DHHS, 2004.
  2. Dashe, J.S.; Jackson, G.L.; Olscher, D.A.; Zane, E.H.; y Wendel, G.D., Jr. Opioid detoxification in pregnancy. Obstet Gynecol 92(5):854-858, 1998.
  3. Dole, V.P.; Nyswander, M.E.; y Kreek, M.J. Narcotic blockade. Arch Intern Med 118(4):304-309, 1966.
  4. Goldstein, A. Heroin addiction: Neurology, pharmacology, and policy. J Psychoactive Drugs 23(2):123-133, 1991.
  5. Hughes, P.H.; y Rieche, O. Heroin epidemics revisited. Epidemiol Rev 17(1):66-73, 1995.
  6. Hulse, G.K.; Milne, E.; English, D.R.; y Holman, C.D.J. The relationship between maternal use of heroin and methadone and infant birth weight. Addiction 92(11):1571-1579, 1997.
  7. Jansson, L.M.; Svikis, D.; Lee, J.; Paluzzi, P.; Rutigliano, P.; y Hackerman, F. Pregnancy and addiction; a comprehensive care model. Journal of Substance Abuse Treatment 13(4):321-329, 1996.
  8. Jarvis, M.A.; y Schnoll, S.H. Methadone use during pregnancy. NIDA Research Monograph 149, 58-77, 1995.
  9. Johnson, R.E.; Jones, H.E.; y Fischer, G. Use of buprenorphine in pregnancy: patient management and effects on neonate. Drug and Alcohol Dependence 70(2):S87-S101, 2003.
  10. Jones, H.E. Practical Considerations for the Clinical Use of Buprenorphine. Science & Practice Perspectives 2(2):4-20, 2004.
  11. Kornetsky, C. Action of opioid on the brain-reward system. In: Rapaka, R.S.; and Sorer, H.; eds. Discovery of Novel Opioid Medications. National Institute on Drug Abuse Research Monograph 147. NIH Pub. No. 95-3887. Washington, DC: Supt. of Docs., U.S. Govt. Print Off., 1991, pp. 32-52.
  12. Kreek, M.J. Using methadone effectively: Achieving goals by application of laboratory, clinical, and evaluation research and by development of innovative programs. In: Pickens, R.; Leukefeld, C.; and Schuster, C.R.; eds. Improving Drug Abuse Treatment. National Institute on Drug Abuse Research Monograph 106. Washington, DC: Supt. of Docs., U.S. Govt. Print. Off., 1991, pp. 245-266.
  13. Lewis, J.W.; y Walter, D. Buprenorphine: Background to its development as a treatment for opiate dependence. In: Blaine, J.D., ed. Buprenorphine: An Alternative for Opiate Dependence. National Institute on Drug Abuse Research Monograph 121. DHHS Pub. No. (ADM) 92-1912. Washington, DC: Supt. of Docs., U.S. Govt. Print. Off., 1992, pp. 5-11.
  14. Luty, J.; Nikolaou, V.; y Bearn, J. Is opiate detoxification unsafe in pregnancy? J Subst Abuse Treat 24(4):363-367, 2003.
  15. Maas, U.; Kattner, E.; Weingart-Jesse, B.; Schafer, A.; y Obladen, M. Infrequent neonatal opiate withdrawal following maternal methadone detoxification during pregnancy. J Perinat Med 18(2):111-118, 1990.
  16. Mathias, R. NIDA survey provides first national data on drug abuse during pregnancy. NIDA NOTES 10:6-7, 1995.
  17. Messinger, D.S.; Bauer, C.R.; Das, A.; Seifer, R.; Lester, B.M.; Lagasse, L.L.; Wright, L.L.; Shankaran, S.; Bada, H.S.; Smeriglio, V.L.; Langer, J.C.; Beeghly, M.; y Poole, W.K. The maternal lifestyle study: cognitive, motor, and behavioral outcomes of cocaine-exposed and opiate-exposed infants through three years of age. Pediatrics 113(6):1677-1685, 2004.
  18. National Institute on Drug Abuse. “Heroin.” NIDA Capsule. NIDA, 1986. National Institute on Drug Abuse. IDUs and infectious diseases. NIDA NOTES 9:15, 1994.
  19. National Institute on Drug Abuse. Monitoring the Future, National Results on Adolescent Drug Use, Overview of Key Findings 2004. NIH Pub. No. 05-5726. Washington, DC: Supt. of Docs., U.S. Govt. Print. Off., 2005.
  20. Novick, D.M.; Richman, B.L.; Friedman, J.M.; Frieman, J.E.; Fried, C.; Wilson, J.P.;
  21. Townley, A.; and Kreek, M.J. The medical status of methadone maintained patients in treatment for 11-18 years. Drug and Alcohol Depend 33(3):235-245, 1993.
  22. Office of Applied Studies. Results from the 2003 National Survey on Drug Use and Health: National Findings. DHHS Pub. No. (SMA) 04-3964. SAMHSA, 2004.
  23. Office of National Drug Control Policy. Heroin Facts and Figures. Rockville, MD, 2004. Se puede encontrar en www.whitehousedrugpolicy. gov/drugfact/heroin/index.html.
  24. Sobel, K. NIDA’s AIDS projects succeed in reaching drug addicts, changing high-risk behaviors. NIDA NOTES 6:25-27, 1991.
  25. Substance Abuse and Mental Health Services Administration Office of Applied Studies. Emergency Department Trends From the Drug Abuse Warning Network, Final Estimates 1995-2002. DHHS Pub. No. (SMA) 63-3780. Rockville, MD: SAMHSA, 2003.
  26. Swan, N. Research demonstrates long-term benefits of methadone treatment. NIDA NOTES 9:1, 4-5, 1994.
  27. Woods, J.H.; France, C.P.; y Winger, G.D. Behavioral pharmacology of buprenorphine: Issues relevant to its potential in treating drug abuse. En: Blain, J.D., ed. Buprenorphine: An Alternative for Opiate Dependence. National Institute on Drug Abuse Research Monograph 121. DHHS Pub. No. (ADM) 92-1912. Washington, DC: Supt. of Docs., U.S. Govt. Print. Off., 1992, pp. 12-27.

Página actualizada en octubre del 2005

Serie de reportes de investigación

Esta serie de reportes, dirigida al público en general, los legisladores, los grupos educativos y los profesionales de la salud, explica la ciencia detrás de los resultados de la investigación.  La serie informa sobre los resultados de las investigaciones de interés nacional.

Toma el reto nacional sobre el coeficiente intelectual (CI) sobre las drogas